Samuel Hume, Fellow at The Foulkes Foundation and pursuing PhD in the University of Oxford’s Department of Oncology, shared a post on X:
“What new drugs have been FDA-approved so far in 2025?
Among them is an antibiotic with a unique mode-of-action, a new antibody-drug conjugate for breast cancer, and the first pain medication that’s selective for the NaV1.8 sodium channel.”
FDA new drug approvals in Q1 2025
Author: Paul Verdin
Learn more about new drug developments in oncology on OncoDaily.